Glenmede Trust’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $439K | Sell |
6,663
-6,107
| -48% | -$388K | ﹤0.01% | 1011 |
|
|
2025
Q4 | $811K | Buy |
+12,770
| New | +$794K | ﹤0.01% | 781 |
|
|
2024
Q4 | – | Sell |
-6,261
| Closed | -$331K | – | 1399 |
|
|
2024
Q3 | $331K | Sell |
6,261
-2,761
| -31% | -$154K | ﹤0.01% | 1066 |
|
|
2024
Q2 | $489K | Buy |
9,022
+994
| +12% | +$60K | ﹤0.01% | 914 |
|
|
2024
Q1 | $563K | Buy |
8,028
+4,210
| +110% | +$326K | ﹤0.01% | 892 |
|
|
2023
Q4 | $319K | Sell |
3,818
-6,264
| -62% | -$227K | ﹤0.01% | 1018 |
|
|
2023
Q3 | $297K | Sell |
10,082
-2,161
| -18% | -$72K | ﹤0.01% | 992 |
|
|
2023
Q2 | $431K | Hold |
12,243
| – | – | ﹤0.01% | 871 |
|
|
2023
Q1 | $431K | Sell |
12,243
-823
| -6% | -$33.6K | ﹤0.01% | 876 |
|
|
2022
Q4 | $599K | Sell |
13,066
-247
| -2% | -$10.6K | ﹤0.01% | 793 |
|
|
2022
Q3 | $645K | Sell |
13,313
-5,611
| -30% | -$270K | ﹤0.01% | 755 |
|
|
2022
Q2 | $743K | Buy |
18,924
+6,654
| +54% | +$268K | ﹤0.01% | 750 |
|
|
2022
Q1 | $451K | Buy |
12,270
+164
| +1% | +$5.83K | ﹤0.01% | 926 |
|
|
2021
Q4 | $551K | Buy |
12,106
+459
| +4% | +$17.7K | ﹤0.01% | 898 |
|
|
2021
Q3 | $416K | Buy |
+11,647
| New | +$343K | ﹤0.01% | 946 |
|
|
2020
Q4 | – | Sell |
-982
| Closed | -$21K | – | 1476 |
|
|
2020
Q3 | $21K | Buy |
982
+73
| +8% | +$1.71K | ﹤0.01% | 1598 |
|
|
2020
Q2 | $21K | Buy |
909
+474
| +109% | +$8.89K | ﹤0.01% | 1567 |
|
|
2020
Q1 | $4K | Hold |
435
| – | – | ﹤0.01% | 2710 |
|
|
2019
Q4 | $4K | Sell |
435
-173
| -28% | -$1.78K | ﹤0.01% | 2710 |
|
|
2019
Q3 | $6 | Buy |
608
+107
| +21% | +$1.34K | ﹤0.01% | 2557 |
|
|
2019
Q2 | $5 | Buy |
501
+215
| +75% | +$2.07K | ﹤0.01% | 2617 |
|
|
2019
Q1 | $2 | Buy |
286
+62
| +28% | +$456 | ﹤0.01% | 2821 |
|
|
2018
Q4 | $1 | Buy |
+224
| New | +$1.64K | ﹤0.01% | 2873 |
|
|
2016
Q4 | – | Sell |
-88
| Closed | – | – | 2497 |
|
|
2016
Q3 | $0 | Buy |
+88
| New | +$919 | ﹤0.01% | 2600 |
|
|
2013
Q4 | – | Sell |
-17,905
| Closed | -$138K | – | 2285 |
|
|
2013
Q3 | $138K | Buy |
+17,905
| New | +$192K | ﹤0.01% | 1265 |
|
Other funds holding CYTK
VPM
VCM
ACA
